CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- SC 13D/A Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13D/A Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-3/A Offering F-3/A
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Derivatives Options or other derivatives
- 6-K Event Report of Foreign Issuer
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- RW Other RW
- S-1/A Offering Registration Statement
Page 5 of 19 · 368 filings